43.8 F
New York
Sunday, January 29, 2023

Date:

Share:

Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company

Related Articles

Careington Proud to Sponsor 13th Annual Dr. Martin Luther King Jr. Essay and Oration Scholarship Competition

Frisco, TX, January 29, 2023 --(PR.com)-- Careington is proud to have served another year as a "Dream" level sponsor for the 13th annual Dr. Martin...

Dr. Patrick Hsu Named One of Texas Super Doctors 2022

Houston, TX, January 27, 2023 --(PR.com)-- Dr. Patrick Hsu of Memorial Plastic Surgery has been named one of the Texas Super Doctors by Super Doctors...
Oulu, Finland, November 29, 2022 –(PR.com)– “It is very encouraging when appreciation comes to Paras Biopharmaceuticals, especially from a USA-based company that is very innovative in its work and is developing challenging next generation biologics. Paras Biopharmaceuticals proudly shares its recommendation and appreciation of its USA-based customer who we served in 2021/2022,” says Dr. Mark Jackson, Administration Lead of Paras Biopharmaceuticals.

Recommendation from a Biotech company in the San Francisco Bay area, USA – Director, CMC/Pharmaceutical Development

“Paras Biopharmaceuticals is a solid company to generate pilot-scale material with high quality. The scientists at Paras Biopharmaceuticals’ upstream, downstream, and analytical groups are experienced in process operation and analytical assay transfer. The project manager and technical lead are responsible and well-organised. When we initiate our project with a…

Read more…

Popular Articles